We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

NDA:XETRAurubis AG Analysis

Data as of 2026-05-27 - not real-time

$90.88

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

Technical outlook: The stock is trading just above its 20‑day SMA and roughly aligned with its 50‑day SMA, indicating a neutral price stance. Momentum gauges show a mid‑range RSI and a bearish MACD histogram, while volume has been trending down, suggesting limited short‑term upside. Support sits just below the current level and resistance is a few points higher, framing a tight range.
Fundamental backdrop: Revenue growth remains solid at double‑digit rates and operating margins are robust, backed by strong operating and free cash flow. The dividend payout ratio is modest, supporting dividend sustainability. However, the market price is well above the DCF‑derived fair value and carries a PE multiple that exceeds the industry average, pointing to an overvalued valuation despite growth credentials.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near short‑term moving averages
  • Bearish MACD histogram
  • Decreasing volume trend

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Consistent double‑digit revenue growth
  • Strong operating and free cash flow generation
  • Sustainable dividend with low payout ratio

Long Term

> 3 years
Neutral
Model confidence: 7/10

Key Factors

  • Overvalued price relative to DCF fair value
  • High operating margins supporting earnings stability
  • Exposure to regulatory environment in financial data sector

Key Metrics & Analysis

Financial Health

Revenue Growth13.70%
Profit Margin35.28%
P/E Ratio27.4
ROE16.20%
ROA5.55%
Debt/Equity79.06
P/B Ratio4.3
Op. Cash Flow$2.3B
Free Cash Flow$1.6B
Industry P/E16.7

Technical Analysis

TrendNeutral
RSI55.3
Support$87.32
Resistance$93.63
MA 20$90.51
MA 50$87.97
MA 200$90.23
MACDBearish
VolumeDecreasing
Fear & Greed Index91.21

Valuation

Fair Value$47.74
Target Price$106.47
Upside/Downside17.15%
GradeOvervalued
TypeGrowth
Dividend Yield1.23%

Risk Assessment

Beta0.74
Volatility18.24%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.